College of Pharmacy

7 Greenhouse Road Kingston, RI 02881

pharmcol@etal.uri.edu – Office: 401.874.2761 Fax: 401.874.2181

URI
Think Big, We Do.
Rhode Island Seal
Follow us on TwitterVisit our Facebook page
 
 
ACPE logo

The University of Rhode Island Doctor of Pharmacy program is accredited by the Accreditation Council for Pharmacy Education.

Continuing Professional Development

Office of Continuing Professional Development

sbs14banner2

Hyatt  Regency Newport Hotel, 1 Goat Island, Newport RI 02840

Plenary Sessions

Thursday & Friday, March 13 & 14, 2014

2-Day Agenda

 

Thursday, March 13, 2014

7:00 AM           Registration, Breakfast and Exhibits, Grand Ballroom Foyer and Brenton Hall

8:00 AM          Welcome, Overview and Awards, Grand Ballroom

8:15 AM          Keynote Presentation
Unlocking the Value of the Pharmacist:
Leadership Pearls for the Extraordinary Pharmacy Leader
Captain Mark E. Brouker, Pharm.D., MBA, BCPS, FACHE
United States Navy (retired) UAN 0060-0000-14-031-L04-P

9:15 AM          Eight Things Everyone Should Know About Drug Interactions
Philip Hansten, PharmD, Professor Emeritus
School of Pharmacy, University of Washington UAN 0060-0000-14-032-L01-P

10:15 AM          Break, Brenton Hall

10:30 AM          Updates in the Management of Hyperlipidemia:  Evidence and Controversies
Tracey Taveira, PharmD, CDOE, Associate Professor
College of Pharmacy, University of Rhode Island     UAN 0060-0000-14-033-L01-P

11:30 AM          How Sweet It Is: 2013 Diabetes Update 
Susan Cornell, BS, PharmD, CDE, FAPhA, FAADE
Assistant Director of Experiential Education & Associate Professor of Pharmacy Practice
College of Pharmacy, Midwestern University Chicago     UAN 0060-0000-14-034-L01-P

12:30 PM          Luncheon and Exhibits, Rose Island Room and Brenton Hall

1:45   PM          Current Trends and Health Information System Tools
Joyce A. Generali, MS, RPh, FASHP
Director, Drug Information Center, Kansas University Hospital
Clinical Professor, School of Pharmacy, Kansas University UAN 0060-0000-14-035-L02-P

2:45   PM          Immunization Update:  What’s New with the Flu… and Other Vaccines, Too?
Brett Feret, PharmD
Clinical Associate Professor & Coordinator, Introductory Pharmacy Practice Experiences
College of Pharmacy, University of Rhode Island     UAN 0060-0000-14-036-L01-P

3:45   PM          Break, Brenton Hall

4:00   PM          Update on Government Healthcare Investigations*
Charles W. Normand, JD
Hinckley Allen, Providence, RI    UAN 0060-0000-14-037-L03-P

5:00   PM          Wrap Up and Evaluations

5:30   PM          Exhibits and Networking Reception, Brenton Hall

 


Friday, March 14, 2014

7:00 AM          Registration, Breakfast, and Exhibits, Grand Ballroom Foyer and Brenton Hall

8:00 AM          Welcome and Overview, Grand Ballroom

8:15 AM          How Can A Pharmacist Add Value to Health Reform?
Kathleen Hittner, MD          UAN 0060-0000-14-038-L04-P
Health Insurance Commissioner
Office of the Health Insurance Commissioner, State of Rhode Island

9:15 AM          The Pharmacist’s Role in Patient Care Transitions
Lynne Chase, Senior Program Administrator, Healthcentric Advisors     UAN 0060-0000-14-039-L04-P
Liaison, Washington County Transitions Coalition
Jennifer W. Fairbank RN, BSN, CNHA
Executive Director, South County Nursing and Rehabilitation Center

10:15 AM          Break, Brenton Hall

10:30 AM          Expanding Roles in Pharmacy Practice
Pharmacist Initiation of Post-Exposure Doxycycline for Lyme Prophylaxis
Anita Jackson, PharmD          UAN 0060-0000-14-040-L01-P
Clinical Assistant Professor, College of Pharmacy, University of Rhode Island

11:30 AM          Phido’s in the Pharmacy:  The Evolving Interface of Veterinary Prescribing with Human Medicine
Catherine M. McClain, RPh, DVM            UAN 0060-0000-14-041-L01-P
Veterinarian, VCA Turco Animal Hospital, Westerly, Rhode Island

12:30 PM          Luncheon and Exhibits, Rose Island Room and Brenton Hall

1:45 PM          Medication Use During Pregnancy and Breast-Feeding
Kristina Ward, PharmD, BCPS            UAN 0060-0000-14-042-L04-P
Clinical Associate Professor and Director, Drug Information Services
College of Pharmacy, University of Rhode Island

2:45 PM          Pharmacist Prescriptive Authority and Pharmacist Clinician
Catherine J. Cone, PharmD, PhC, BCPS        UAN 0060-0000-14-043-L04-P
Assistant Professor of Pharmacy Practice and Administrative Sciences
College of Pharmacy, University of New Mexico Health Sciences Center

3:45 PM          Break, Brenton Hall

4:00 PM          Pharmacy Law: Compounding in the Aftermath of a National Crisis*
Karen Ryle, MS, RPh                 UAN 0060-0000-14-044-L03-P
President, National Association of Boards of Pharmacy (NABP)
Member, Massachusetts Board of Registration in Pharmacy
Associate Chief of Pharmacy, Ambulatory Care, Massachusetts General Hospital

5:30PM          Wrap Up and Evaluations

Adjournment

LEARNING OBJECTIVES

Upon completion of the 2-day application- and knowledge-based learning activities, participants will be able to:

Day One

  1. Identify three leadership skills for a pharmacy leader to employ that will build and motivate a pharmacy team;
  2. Demonstrate examples of caring and optimistic leadership in a pharmacy setting;
  3. Explain the importance of a pharmacy leader consistently treating all staff with dignity and respect;
  4. Summarize the 2014 changes to recent national guidelines for the care of patients with diabetes;
  5. Compare various guidelines in the management of hyperglycemia, hypertension, and dyslipidemia;
  6. Identify current and emerging pharmacotherapy treatments for type 2 diabetes;
  7. Compare common adverse drug effects of current diabetes pharmacotherapy to key side effects that should be minimized based on national guidelines;
  8. Describe 3 important principles in the evaluation of drug interaction evidence;
  9. Describe how mitigating factors and risk factors are used to evaluate the importance of drug interactions in specific patients;
  10. Discuss the 3 primary methods for minimizing the risk of drug interactions in specific patients.
  11. Discuss current influenza trends, including H7N9 and the role of newer influenza vaccinations
  12. Describe the role and schedule of both pneumococcal vaccines (PPSV23 and PCV 13)
  13. Outline all changes in ACIP vaccination recommendations

Day Two

 

  1. Describe the incidence, prevalence, and transmission of Lyme disease nationally and locally from an infectious disease and public health perspective.
  2. List the acute symptoms and potential long-term sequelae of Lyme disease.
  3. Identify specific methods for reducing the risk of acquiring Lyme disease, including ways to decrease tick exposure and the proper use, efficacy, and toxicity of post-exposure doxycycline.
  4. Explain which patients are appropriate candidates for pharmacist initiated post-exposure doxycycline treatment under collaborative practice agreement.
  5. Describe how to support and participate in future endeavors for enhancing public access to Lyme prophylaxis in the pharmacy setting.
  6. Identify and clarify differences in dosing and indications for common medications used in both humans and animals;
  7. Describe medications used uniquely in animals that some retail pharmacies have started to provide;
  8. Discuss the impact to the public as a result of contaminated methylprednisolone throughout the country;
  9. Discuss the change in landscape for compounding pharmacies as a result of the compounding tragedy;
  10. Describe recent federal legislation aimed at increasing the FDA’s oversight of certain compounding pharmacies;
  11. Describe the role of a state board of pharmacy in regulating compounding pharmacies;
  12. Differentiate between collaborative drug therapy management (CDTM) and pharmacist prescriptive authority;
  13. List the requirements for certification as a pharmacist clinician (PhC);
  14. Describe necessary components of a CDTM or PhC protocol.
  15. Identify sources of information containing information about drug use during pregnancy and breastfeeding
  16. Differentiate between risk categories for drug use during pregnancy and breastfeeding.
  17. Discuss pharmacokinetic properties that affect drug transfer to the placenta and breast milk.
  18. Analyze available resources to determine appropriate pharmacotherapeutic options during pregnancy and breastfeeding.
  19. Devise a strategy to ensure that a pregnant woman or breastfeeding mother can receive appropriate pharmacotherapy while minimizing risk to the fetus/infant.

TARGET AUDIENCE

Community, hospital, managed care and consultant pharmacists, nurse practitioners, nurses and other interested health care professionals.

Continuing Education (CPE) Credits

Thursday and Friday, March 13 & 14, 2014 participants will receive up to 0.75 CEUs (7.5 contact hours) for each day of attendance up to a total of 1.5 CEUs (15 contact hours.) *One contact hour of law credit will be awarded each day to Thursday and Friday attendees. One Contact Hour of immunization credit will be awarded to Thursday attendees. The University Of Rhode Island College Of Pharmacy is accredited by the Accreditation Council on Pharmacy Education as a provider of continuing pharmacy education. Attendance and completion of online program evaluations and self-assessment tools at the conclusion of the program are required to print a statement of credit. This program includes application and knowledge-based learning activities.

Copyright © 2014 University of Rhode Island.

The University of Rhode Island
Think Big, We Do.
A-ZDirectoryContact UsJump to top